FRIEDREICH ATAXIA

Clinical trials for FRIEDREICH ATAXIA explained in plain language.

Never miss a new study

Get alerted when new FRIEDREICH ATAXIA trials appear

Sign up with your email to follow new studies for FRIEDREICH ATAXIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 4 Not yet finished but already full! 4 Completed 4 Terminated 1

Terminated trial tests First-of-its-Kind treatment for kids with rare nerve disease

Disease control Terminated

This study aimed to test the safety of a new drug called nomlabofusp in children and teenagers with Friedreich's ataxia, a rare genetic disorder that damages the nervous system. The trial was small, involving about 18 participants, and was designed to see how their bodies handled…

Matched conditions: FRIEDREICH ATAXIA

Phase: PHASE1 • Sponsor: Larimar Therapeutics, Inc. • Aim: Disease control

Last updated Mar 30, 2026 14:35 UTC

FRIEDREICH ATAXIA

Get alerted when new FRIEDREICH ATAXIA trials appear

Terminated trial tests First-of-its-Kind treatment for kids with rare nerve disease